CTI regains compliance with all applicable NASDAQ listing standards Cell Therapeutics, Inc.e., NASDAQ Listing Guideline 5550) for continuing listing on The NASDAQ Capital Marketplace and that CTI is normally in compliance with all relevant listing standards. As a result, the scheduled hearing, which CTI previously announced in a news release dated May 6, 2011, before the NASDAQ Listing Qualifications Panel has been cancelled and CTI’s common stock will continue to be listed and traded on The NASDAQ CURRENCY MARKETS. Supply Cell Therapeutics, Inc.Babies identified as having BPD receive intense supportive treatment in a healthcare facility first, usually in a neonatal intensive treatment unit until they can breathe well on their own, without the support of a mechanical ventilator. Some babies gets jet ventilation also, a continuing low-pressure ventilation that helps minimize the lung harm from ventilation that contributes to BPD. Not this process can be used by all hospitals to take care of BPD, but some with large NICUs do.